CYP1A1 and GSTM1 genes associated with the risk of developing colorectal cancer: a case-control study in the Lima region of Peru

dc.contributor.authorAlvarado, Angel T.
dc.contributor.authorSaravia Bartra, María
dc.contributor.authorMalpartida Palomino, Robert
dc.contributor.authorCárdenas Guerrero, Cynthya Carolin
dc.contributor.authorGarcía, Jorge A.
dc.contributor.authorBendezú, María R.
dc.contributor.authorChávez, Haydee
dc.contributor.authorLaos Anchante, Doris
dc.contributor.authorPalomino Jhong, Juan J.
dc.contributor.authorMolina Cabrera, Aura
dc.contributor.authorCuba Garcia, Pompeyo
dc.contributor.authorMelgar Merino, Elizabeth J.
dc.contributor.authorVega Ramos, Nelly
dc.contributor.authorSurco Laos, Felipe
dc.contributor.authorYarasca Carlos, Paulina Eliades
dc.contributor.authorVarela, Nelson
dc.contributor.authorQuiñones, Luis Abel
dc.contributor.authorCáceres Lillo, Dante Daniel
dc.contributor.authorZavaleta, Amparo Iris
dc.contributor.authorPineda Pérez, Mario
dc.date.accessioned2026-03-31T15:46:18Z
dc.date.available2026-03-31T15:46:18Z
dc.date.issued2025
dc.description.abstractThe presence of CYP1A1 allelic variants and deletion of the glutathione S-transferase GSTM1 gene, and their imbalance, have been suggested as risk factors for inducing colorectal cancer (CRCa). The objective was to identify CYP1A1 and GSTM1 and evaluate the association with the risk of developing colorectal cancer in a sample of cases and controls from Lima, Peru. This was a case-control study of CYP1A1 and GSTM1 genes in 50 samples from patients diagnosed with colorectal cancer and 50 samples from controls without cancer, using the PCR-based restriction fragment length polymorphism method. A significant risk of developing CRCa was found in the following groups: GSTM1*0 carriers with no history of smoking or family history of cancer (OR = 3.56, 95% CI 1.43–8.88, p = 0.0060); GSTM1*0 with family history of cancer without smoking (OR = 2.81, 95% CI 0.35–22.49, p = 0.3280); GSTM1*0 exacerbated by smoking (OR = 1.41, 95% CI 0.11–17.11, p = 0.7880); CYP1A1*2A/*2A carriers with family history and smoking (OR = 1.50, 95% CI 0.13–16.54, p = 0.7410). An association of wild genotypes exacerbated by non-genetic factors with risk of developing CRCa was also found: CYP1A1*1A/*1A with family history of cancer but no history of smoking (OR = 2.94, 95% CI 0.11–35.80, p = 0.6380); GSTM1 (+) with history of smoking but no family history of cancer (OR = 5.63, 95% CI 0.46–68.46, p = 0.1750); GSTM1 (+) associated with family history and smoking (OR = 9.86, 95% CI 1.77–54.89, p = 0.0090). According to univariate statistical analysis, carriers of CYP1A1*2A and GSTM1*0 without association with family history of cancer and smoking would not be related to the risk of CRCa. An association was established between GSTM1*0 and CYPA1*2A/*2A with colorectal cancer exacerbated by family history and smoking. The risk is higher with wild-type genotypes of CYP1A1*1A/*1A and GSTM1 (+) induced by family history and smoking, respectively.
dc.formatapplication/pdf
dc.identifier.doi10.3897/pharmacia.72.e156391
dc.identifier.urihttps://hdl.handle.net/20.500.13028/7422
dc.language.isoeng
dc.publisherPensoft Publishers
dc.relation.isPartOfurn:issn:04280296
dc.relation.ispartofPharmacia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcolorectal cancer
dc.subjectCYP1A1
dc.subjectfamily history
dc.subjectGSTM1
dc.subjectsmoking
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.01.00
dc.titleCYP1A1 and GSTM1 genes associated with the risk of developing colorectal cancer: a case-control study in the Lima region of Peru
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
CYP1A1 and GSTM1 genes associated with the risk of developing colorectal cancer: a case-control study in the Lima region of Peru.pdf
Tamaño:
1.67 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
1.27 KB
Formato:
Item-specific license agreed upon to submission
Descripción: